Sugi Predict

Sugi Predict / Compounds / SCHEMBL2269347

SCHEMBL2269347

SCHEMBL2269347

CCCC(=O)N[C@@H](C)C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 5/20 0.59
▸ ALDH1A1 P00352 3/20 0.56
▸ MAPT P10636 1/20 0.56
▸ SMN1; SMN2 Q16637 3/20 0.56
▸ SLC6A5 Q9Y345 1/20 0.56
▸ HDAC3 O15379 2/20 0.46
▸ HDAC1 Q13547 2/20 0.46
▸ HDAC2 Q92769 2/20 0.46
▸ HDAC8 Q9BY41 2/20 0.46
▸ HDAC6 Q9UBN7 1/20 0.46
▸ MME P08473 1/20 0.46
▸ ACE P12821 1/20 0.46
▸ CPA1 P15085 1/20 0.46
▸ ACE2 Q9BYF1 1/20 0.46
▸ KMT2A Q03164 2/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ CTSD P07339 1/20 0.44
▸ KDM4E B2RXH2 3/20 0.44
▸ TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5401 1.00 FAAH (0.59) FAAHALDH1A1MAPTSMN1; SMN2SLC6A5
SCHEMBL9651263 1.00 FAAH (0.59) FAAHALDH1A1MAPTSMN1; SMN2SLC6A5
Alanine SCHEMBL4454120 0.92 FAAH (0.53) FAAHALDH1A1MAPTSMN1; SMN2SLC6A5
SCHEMBL9864028 0.92 FAAH (0.53) FAAHALDH1A1MAPTSMN1; SMN2SLC6A5
SCHEMBL5966860 0.87 FAAH (0.70) FAAHALDH1A1MAPTSMN1; SMN2SLC6A5
SCHEMBL5296255 0.87 FAAH (0.70) FAAHALDH1A1MAPTSMN1; SMN2SLC6A5
SCHEMBL5966857 0.87 FAAH (0.70) FAAHALDH1A1MAPTSMN1; SMN2SLC6A5
SCHEMBL9377518 0.85 FAAH (0.78) FAAHALDH1A1MAPTSMN1; SMN2SLC6A5
SCHEMBL5936930 0.85 FAAH (0.78) FAAHALDH1A1MAPTSMN1; SMN2SLC6A5
SCHEMBL101698 0.85 FAAH (0.78) FAAHALDH1A1MAPTSMN1; SMN2SLC6A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3366273-B1 MOISTURIZER AND COSMETIC CONTAINING SAME AJINOMOTO KK (JP) 2025-07-09 — — EP disclosed
US-20250000948-A1 SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID ADOCIA (FR) 2025-01-02 — — US disclosed
EP-4433093-A1 SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID Adocia (FR) 2024-09-25 — — EP disclosed
CN-118488855-A Solid composition comprising peptide or protein and acylated amino acid 阿道恰公司 2024-08-13 — — CN disclosed
EP-4299057-A1 SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID Adocia (FR) 2024-01-03 — — EP disclosed
WO-2023168367-A1 QUINOLINE cGAS ANTAGONIST COMPOUNDS IMMUNESENSOR THERAPEUTICS, INC. (US) 2023-09-07 — — WO disclosed
WO-2023084118-A1 SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID ADOCIA (FR) 2023-05-19 — — WO disclosed
EP-4180060-A1 SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID Adocia (FR) 2023-05-17 — — EP disclosed
US-20230122228-A1 NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS ENANTA PHARMACEUTICALS, INC. 2023-04-20 — — US disclosed
US-10406086-B2 Moisturizer and cosmetic including the same AJINOMOTO CO., INC. (JP) 2019-09-10 — — US disclosed
WO-2016207098-A1 ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITORS WITH ANTI-CD123-ANTIBODIES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2016-12-29 — — WO disclosed
WO-2016207094-A1 ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITORS WITH ANTI-TWEAKR-ANTIBODIES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2016-12-29 — — WO disclosed
US-9018172-B2 Modification of peptides via SNAr reactions of thiols with fluorinated aromatics MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2015-04-28 — — US disclosed
WO-2014176279-A1 POLYMER-BASED PROTEIN ENGINEERING METHODS TO RATIONALLY TUNE ENZYME ACTIVITY, PH-DEPENDENCE AND STABILITY CARNEGIE MELLON INIVERSITY (US) 2014-10-30 — — WO disclosed
US-20140113871-A1 Modification of Peptides via SNAr Reactions of Thiols with Fluorinated Aromatics MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2014-04-24 — — US disclosed
US-7993931-B1 Oxygen-18 labeled organic acids and use in diagnosing metabolic disorders QUEST DIAGNOSTICS INVESTMENTS INCORPORATED (US) 2011-08-09 — — US disclosed
US-4308384-A Production of triazinones GLAXO GROUP LIMITED (GB) 1981-12-29 — — US disclosed
US-4278673-A Pharmacologically active compounds ALLEN & HANBURYS LIMITED (GB) 1981-07-14 — — US disclosed
EP-0009384-A1 Processes for the preparation of triazinones and condensed triazinones, and compounds so obtained GLAXO GROUP LIMITED (GB) 1980-04-02 — — EP disclosed
US-3941666-A NEUTRALIZATION OF AN N-ACYL-ALPHA-AMINOPROPIONIC ACID, ELECTROLYSIS HOECHST AKTIENGESELLSCHAFT (DT) 1976-03-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250000948-A1 SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID NPPA, BCAT1, ANPEP FAAH 858/4885ALDH1A1 4701/4885MAPT 2383/4885
US-20140113871-A1 Modification of Peptides via SNAr Reactions of Thiols with Fluorinated Aromatics PTMS, SSTR4, QRFPR FAAH 2822/4885ALDH1A1 3064/4885MAPT 1001/4885
US-20230122228-A1 NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS ACE, ACE2, PKD1 FAAH 3461/4885ALDH1A1 386/4885MAPT 4226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.